Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
40%
Ph phase_1
1
20%
Ph phase_3
1
20%
Ph phase_4
1
20%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Other(1)

Detailed Status

Completed3
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (20.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)
N/A2 (40.0%)

Trials by Status

completed360%
recruiting120%
unknown120%

Recent Activity

1 active trials
Showing 5 of 5
recruitingphase_3

Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome

NCT07168434
unknownnot_applicable

The Effect of Saccharomyces Boulardii in Clinical Presentation and Quality of Life Patient With IBS

NCT05451433
completednot_applicable

Saccharomyces Boulardii as Pretreatment Before Rescue Therapy of Helicobacter Pylori

NCT05191875
completedphase_4

Efficacy and Safety of Saccharomyces Boulardii in the Treatment of Small Intestinal Bacterial Overgrowth

NCT04627337
completedphase_1

Effect Of A Locally Delivered Probiotic Sacchraomyces Boulardii In The Management Of Chronic Periodontitis

NCT03516370

Clinical Trials (5)

Showing 5 of 5 trials
NCT07168434Phase 3

Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome

Recruiting
NCT05451433Not Applicable

The Effect of Saccharomyces Boulardii in Clinical Presentation and Quality of Life Patient With IBS

Unknown
NCT05191875Not Applicable

Saccharomyces Boulardii as Pretreatment Before Rescue Therapy of Helicobacter Pylori

Completed
NCT04627337Phase 4

Efficacy and Safety of Saccharomyces Boulardii in the Treatment of Small Intestinal Bacterial Overgrowth

Completed
NCT03516370Phase 1

Effect Of A Locally Delivered Probiotic Sacchraomyces Boulardii In The Management Of Chronic Periodontitis

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5